Clinical trial
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or…
NCT00002777 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00002777 |
|---|---|
| Title | Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer |
| Official title | RANDOMIZED PHASE II STUDY IN FIRST LINE HORMONAL TREATMENT FOR METASTATIC BREAST CANCER WITH EXEMESTANE OR TAMOXIFEN IN POSTMENOPAUSAL PATIENTS |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | exemestane, tamoxifen citrate |
| Enrollment | 342 |
| Start date | May 1, 1996 |
| Primary completion | Dec 1, 2002 |
| First posted | Apr 11, 2003 |
| Last update posted | Jul 2, 2012 |
| Countries | Australia, Belgium, France, Malaysia, Netherlands, Philippines, Poland, Russia, Slovenia, Taiwan, Thailand, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: